You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Cognitive Behaviour Therapy For The Chronic Fatigue Syndrome: A Randomised Controlled Trial
Michael Sharpe, Keith Hawton, Sue Simkin, Christina Surawy, Ann Hackmann, Ivana Klimes, Tim Peto, David Warrell and Valerie Seagroatt
BMJ: British Medical Journal
Vol. 312, No. 7022 (Jan. 6, 1996), pp. 22-26
Published by: BMJ
Stable URL: http://www.jstor.org/stable/29730217
Page Count: 5
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Objective—To evaluate the acceptability and efficacy of adding cognitive behaviour therapy to the medical care of patients presenting with the chronic fatigue syndrome. Design—Randomised controlled trial with final assessment at 12 months. Setting—An infectious diseases outpatient clinic. Subjects—60 consecutively referred patients meeting consensus criteria for the chronic fatigue syndrome. Interventions—Medical care comprised assessment, advice, and follow up in general practice. Patients who received cognitive behaviour therapy were offered 16 individual weekly sessions in addition to their medical care. Main outcome measures—The proportions of patients (a) who achieved normal daily functioning (Karnofsky score 80 or more) and (b) who achieved a clinically significant improvement in functioning (change in Karnofsky score 10 points or more) by 12 months after randomisation. Results—Only two eligible patients refused to participate. All randomised patients completed treatment. An intention to treat analysis showed that 73% (22/30) of recipients of cognitive behaviour therapy achieved a satisfactory outcome as compared with 27% (8/30) of patients who were given only medical care (difference 47 percentage points; 95% confidence interval 24 to 69). Similar differences were observed in subsidiary outcome measures. The improvement in disability among patients given cognitive behaviour therapy continued after completion of therapy. Illness beliefs and coping behaviour previously associated with a poor outcome changed more with cognitive behaviour therapy than with medical care alone. Conclusion—Adding cognitive behaviour therapy to the medical care of patients with the chronic fatigue syndrome is acceptable to patients and leads to a sustained reduction in functional impairment.
BMJ: British Medical Journal © 1996 BMJ